South Georgia Capital’s AbbVie ABBV Stock Holding History

South Georgia Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$101K	Hold	1,865	–	–	0.25%	35
2015 Q2	$125K	Buy	1,865 +465	+33%	+$30.4K	0.25%	42
2015 Q1	$82K	Hold	1,400	–	–	0.15%	60
2014 Q4	$92K	Sell	1,400 -5,400	-79%	-$340K	0.17%	62
2014 Q3	$383K	Sell	6,800 -11,300	-62%	-$627K	0.57%	28
2014 Q2	$1.02M	Sell	18,100 -19,850	-52%	-$1.04M	1.2%	18
2014 Q1	$1.95M	Sell	37,950 -10,100	-21%	-$510K	1.67%	20
2013 Q4	$2.54M	Buy	+48,050	New	+$2.36M	1.57%	24

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

South Georgia Capital's ABBV Position: Q3 2015 in Review

South Georgia Capital held its AbbVie (ABBV) position steady in Q3 2015 at 1,865 shares worth $101K. The position accounts for 0.25% of the portfolio, ranked #35.

South Georgia Capital first reported a position in ABBV in Q4 2013 and has held it in 8 quarters since. The position peaked at $2.54M in Q4 2013. 1,605 funds tracked by Wall St. Rank hold ABBV as of Q3 2015.

South Georgia Capital held 1,865 shares of AbbVie worth $101K as of Q3 2015.
South Georgia Capital left its AbbVie share count unchanged in Q3 2015.
AbbVie made up 0.25% of South Georgia Capital's portfolio in Q3 2015, its #35 holding.
South Georgia Capital first reported a position in AbbVie in Q4 2013 and has held it in 8 quarters since.
South Georgia Capital's AbbVie position peaked at $2.54M in Q4 2013.
1,605 funds tracked by Wall St. Rank held AbbVie as of Q3 2015.

Based on South Georgia Capital's 13F filing for Q3 2015, filed 10 Nov 2015.